Log In
BCIQ
Print this Print this
 

CXD201

  Manage Alerts
Collapse Summary General Information
Company Celleron Therapeutics Ltd.
DescriptionOral topoisomerase 1 inhibitor
Molecular Target Topoisomerase I (TOP1)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/06/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today